Ivan Chan

Ivan Chan is an experienced professional in the field of immuno-oncology, currently serving as Senior Director at Nkarta, Inc. since February 2019, with previous roles including Director and Associate Director. Prior experience includes positions as Senior Scientist II at OncoMed Pharmaceuticals and ARMO Biosciences, where contributions focused on pre-clinical investigations, assay development, and drug development for immuno-oncology therapies. Early career roles included scientific positions at Merck and a postdoctoral researcher at the University of California, Davis, where research was centered on cytokine signaling and liver cancer models. Ivan Chan holds a Ph.D. and a BS in Biochemistry and Molecular Biology from the University of California, Davis.